Comparative analysis of genes frequently regulated by drugs based on connectivity map transcriptome data

Area of Science:

• Genomics
• Pharmacogenomics
• Computational Biology

Background:

• Drug perturbation of gene expression is a critical factor in therapeutic efficacy and side effect profiles.
• Understanding which genes are frequently modulated by drugs can aid in identifying therapeutic targets and genes involved in adverse drug reactions.

Purpose of the Study:

• To computationally analyze genes with high differential expression numbers (DEN) in response to drug treatments.
• To compare the genomic, functional, and network properties of frequently drug-regulated genes against those with lower regulation.

Main Methods:

• Utilized Affymetrix microarray data from the Connectivity Map project to calculate differential expression number (DEN) for genes.
• Conducted comparative computational analysis of high DEN genes (down_h/up_h) and low DEN genes (down_l/up_l).
• Assessed gene clustering, homologous gene count, SNP density, disease-related SNPs, pathway enrichment, network degree, developmental expression timing, and tissue specificity.

Main Results:

• Genes with high down-/up-regulation numbers (down_h/up_h) showed genomic clustering, lower homology, higher SNP density, and more disease-related SNPs.
• High DEN genes were significantly enriched in cancer-related pathways, while low DEN genes were associated with nervous system disease development.
• Up_h genes exhibited lower network interaction degree, later expression during development, and higher tissue specificity compared to up_l genes; down_h showed opposite trends.

Conclusions:

• Genes frequently targeted by drug-induced expression changes are strongly associated with disease-related functions.
• Drug-induced modulation of broadly conserved and widely expressed genes appears to be disfavored, suggesting a preference for targeting more specific gene sets.